Ceeto Capital Group’s Sangamo Therapeutics SGMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-44,000	Closed	-$330K	–	158
2021 Q4	$330K	Sell	44,000 -15,000	-25%	-$113K	0.14%	125
2021 Q3	$532K	Sell	59,000 -8,000	-12%	-$72.1K	0.25%	91
2021 Q2	$802K	Sell	67,000 -7,000	-9%	-$83.8K	0.36%	74
2021 Q1	$927K	Sell	74,000 -6,000	-8%	-$75.2K	0.45%	64
2020 Q4	$1.25M	Sell	80,000 -3,500	-4%	-$54.6K	0.63%	45
2020 Q3	$789K	Hold	83,500	–	–	0.44%	64
2020 Q2	$748K	Buy	83,500 +33,500	+67%	+$300K	0.48%	60
2020 Q1	$319K	Buy	50,000 +12,000	+32%	+$76.6K	0.26%	94
2019 Q4	$318K	Hold	38,000	–	–	0.21%	105
2019 Q3	$344K	Hold	38,000	–	–	0.25%	102
2019 Q2	$409K	Sell	38,000 -3,000	-7%	-$32.3K	0.3%	92
2019 Q1	$391K	Sell	41,000 -12,000	-23%	-$114K	0.29%	94
2018 Q4	$608K	Hold	53,000	–	–	0.5%	61
2018 Q3	$898K	Buy	53,000 +1,000	+2%	+$16.9K	0.62%	55
2018 Q2	$738K	Buy	52,000 +6,000	+13%	+$85.2K	0.55%	61
2018 Q1	$874K	Buy	+46,000	New	+$874K	0.66%	49